Related Experiment Video
Updated: Jan 16, 2026

Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
Published on: May 18, 2020
Navigating open-source waters: the pharmaceutical industry's role in bioontology development
Shawn Zheng Kai Tan1, Joshua Daniel Valdez1, Saritha Vettikunnel Kuriakose1
1Novo Nordisk A/S, Novo Nordisk Park 1, 2760 Måløv, Denmark.
None:
Bioontologies are core to many data management strategies, artificial intelligence and machine learning initiatives, and search functionality within many pharmaceutical companies. Despite their integral role, many bioontologies, along with their associated tools, are maintained predominantly by academia and their partners, government supported initiatives, and the general community. In this comment, we will dive into some of the reasons behind this trend and argue that there exists a mutual advantage for the life science industry, and pharmaceutical companies in particular, to actively contribute to the advancement of public ontologies and open-source tools. This benefit extends beyond ethical and moral considerations and aligns with strategic interests. Additionally, we will explore practical approaches for contributing, sharing our (Novo Nordisk's research and early development) experience in doing so.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
08:01Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Related Concept Videos
Biopharmaceutics and Pharmacokinetics: Overview
Bioequivalence: Overview
Drug Products: Biologics, Biosimilars and Interchangeables
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Drug Discovery: Overview
Preclinical Development: Overview